LUNG logo

Pulmonx Corporation (LUNG)

Profile

Full Name

Pulmonx Corporation

Ticker

NASDAQ: LUNG

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

October 1, 2020

Indexes

Not included

Website

https://pulmonx.com

Employees

291

Key Details

Price

$1.69(1.81%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$83.79M(22.01% YoY)

Annual EPS

-$1.44(10.00% YoY)

PE Ratio

-

Next earnings date

Oct 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.69
    LUNG price is $1.69

    30-Day Relative Volume

    0.47
    LUNG 30-day relative volume is 0.47

    Price Performance

    Price Most Recent Change

    +1.81%
    LUNG price was up +1.81% on Oct 2, 2025

    Price YTD Change

    -75.11%
    LUNG price is down -75.11% since January 1st

    Price 1-Year Change

    -76.88%
    LUNG price is down -76.88% year-on-year

    Price 3-Year Change

    -90.26%
    LUNG price is down -90.26% over the past 3 years

    Price Range

    Price All-Time High

    $69.48
    LUNG price is currently -97.57% below its historical high of $69.48

    Price 3-Year Low

    $1.47
    LUNG price is currently +14.97% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $68.86M
    LUNG market cap is $68.86 million

    Market Cap 3-Year Change

    -89.39%
    LUNG market cap is down -89.39% over the past 3 years

    Market Cap All-Time High

    $2.46B
    LUNG market cap is currently -97.20% below its historical high of $2.46 billion

    Market Cap Sector Percentile

    35.35%
    LUNG market cap is higher than 35.35% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.19%
    LUNG shares outstanding is up +3.19% year-on-year

    Shares Outstanding 3-Year Change

    +8.92%
    LUNG shares outstanding is up +8.92% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.66
    LUNG beta is 0.66

    200-day SMA

    $4.41
    LUNG price is currently -61.71% below its 200-day simple moving average

    50-day SMA

    $1.81
    LUNG price is currently -6.79% below its 50-day simple moving average

    14-Day RSI

    47.40
    LUNG 14-day relative strength index is 47.40

    Volume

    0.47
    LUNG 30-day relative volume is 0.47

    ATR

    $0.12
    LUNG average true range is $0.12

    10-day Historical Volatility

    68.85%
    LUNG 10-day historical volatility is 68.85%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $83.79M
    LUNG annual revenue is $83.79 million

    Revenue Analysts Estimate

    $90.61M
    LUNG annual revenue is currently -7.53% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +22.01%
    LUNG annual revenue is up +22.01% year-on-year

    Revenue Sector Percentile

    66.97%
    LUNG annual revenue is higher than 66.97% of companies in Healthcare sector

    EPS

    EPS

    -$1.44
    LUNG annual earnings per share is -$1.44

    EPS Analysts Estimate

    -$1.55
    LUNG annual earnings per share is currently -6.78% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +10%
    LUNG annual earnings per share is up +10% year-on-year

    EPS Sector Percentile

    46.58%
    LUNG annual earnings per share is higher than 46.58% of companies in Healthcare sector

    Profit

    Gross Profit

    $62.00M
    LUNG annual gross profit is $62.00 million

    Gross Margin

    74.00%
    LUNG annual gross profit margin is 74.00%

    Operating Profit

    -$57.70M
    LUNG annual operating income is -$57.70 million

    Operating Margin

    -68.87%
    LUNG annual operating profit margin is -68.87%

    Net Income

    -$56.39M
    LUNG annual net profit is -$56.39 million

    Net Margin

    -67.30%
    LUNG annual net profit margin is -67.30%

    Expenses

    Total Expenses

    $141.49M
    LUNG annual total expenses is $141.49 million

    Operating Expenses

    $119.70M
    LUNG annual total operating expenses is $119.70 million

    Cost Of Goods Sold

    $21.79M
    LUNG annual cost of goods sold is $21.79 million

    Selling, General & Administrative Expenses

    $102.14M
    LUNG annual SG&A is $102.14 million

    Depreciation & Amortization

    $1.49M
    LUNG annual D&A is $1.49 million

    Interest Expense

    $3.51M
    LUNG annual interest expense is $3.51 million

    Income Tax

    $500.00K
    LUNG annual income tax is $500.00 thousand

    EBIT & EBITDA

    EBIT

    -$52.39M
    LUNG annual earnings before interest & taxes is -$52.39 million

    EBITDA

    -$52.39M
    LUNG annual EBITDA is -$52.39 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $167.71M
    LUNG annual total assets is $167.71 million

    Non Current Assets

    $26.60M
    LUNG annual long term assets is $26.60 million

    Current Assets

    $136.25M
    LUNG annual total current assets is $136.25 million

    Cash and Cash Equivalents

    $70.91M
    LUNG annual cash & cash equivalents is $70.91 million

    Accounts Receivable

    $13.12M
    LUNG annual accounts receivable is $13.12 million

    Inventory

    $16.91M
    LUNG annual inventory is $16.91 million

    Liabilities

    Total Liabilities

    $81.90M
    LUNG annual total liabilities is $81.90 million

    Long Term Liabilities

    $52.60M
    LUNG annual total long term liabilities is $52.60 million

    Current Liabilities

    $24.44M
    LUNG annual current liabilities is $24.44 million

    Accounts Payable

    $3.83M
    LUNG annual accounts payable is $3.83 million

    Debt

    Total Debt

    $56.47M
    LUNG annual total debt is $56.47 million

    Total Debt 1-Year Change

    +36.32%
    LUNG annual total debt is up +36.32% year-on-year

    Long Term Debt

    $52.52M
    LUNG annual long term debt is $52.52 million

    Short Term Debt

    $3.95M
    LUNG annual short term debt is $3.95 million

    Equity & Capital

    Shareholders Equity

    $85.81M
    LUNG annual stockholders equity is $85.81 million

    Book Value

    $85.81M
    LUNG annual book value is $85.81 million

    Retained Earnings

    -$467.56M
    LUNG annual retained earnings is -$467.56 million

    Working Capital

    $111.81M
    LUNG annual working capital is $111.81 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$31.54M
    LUNG annual cash from operations is -$31.54 million

    Cash From Operations 1-Year Change

    +16.15%
    LUNG annual cash from operations is up +16.15% year-on-year

    Cash From Investing

    $17.48M
    LUNG annual cash from investing is $17.48 million

    Cash From Investing 1-Year Change

    +970.75%
    LUNG annual cash from investing is up +970.75% year-on-year

    Cash From Financing

    $1.36M
    LUNG annual cash from financing is $1.36 million

    Cash From Financing 1-Year Change

    -93.63%
    LUNG annual cash from financing is down -93.63% year-on-year

    CAPEX

    CAPEX

    $1.45M
    LUNG annual capital expenditures is $1.45 million

    CAPEX 1-Year Change

    +79.31%
    LUNG annual capital expenditures is up +79.31% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$32.98M
    LUNG annual free cash flow is -$32.98 million

    Free Cash Flow 1-Year Change

    +14.14%
    LUNG annual free cash flow is up +14.14% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    74.00%
    LUNG annual gross profit margin is 74.00%

    Operating Margin

    -68.87%
    LUNG annual operating profit margin is -68.87%

    Net Margin

    -67.30%
    LUNG annual net profit margin is -67.30%

    ROA & ROE

    ROA

    -32.54%
    LUNG annual return on assets is -32.54%

    ROE

    -55.25%
    LUNG annual return on equity is -55.25%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    LUNG price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    LUNG price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    1.00
    LUNG price to book ratio is 1.00

    PB Ratio Sector Percentile

    33.16%
    LUNG price to book ratio is higher than 33.16% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    0.76
    LUNG price to sales ratio is 0.76

    PS Ratio Sector Percentile

    16.38%
    LUNG price to sales ratio is higher than 16.38% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $41.21M
    LUNG enterprise value is $41.21 million

    Enterprise Value Sector Percentile

    34.75%
    LUNG enterprise value is higher than 34.75% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.74
    LUNG EV/EBITDA is -0.74

    EV/EBITDA Sector Percentile

    51.67%
    LUNG EV/EBITDA is higher than 51.67% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    5.58
    LUNG annual current ratio is 5.58

    Quick Ratio

    4.88
    LUNG annual quick ratio is 4.88

    Leverage

    Debt To Equity

    0.43
    LUNG annual debt to equity ratio is 0.43

    Interest Coverage Ratio

    -14.94
    LUNG annual interest coverage ratio is -14.94

    Risk & Stability

    F-Score

    2
    LUNG piotroski f-score is 2

    Altman Z-Score

    -3.13
    LUNG altman z-score is -3.13

    Analyst ratings

    Recent major analysts updates

    Sep 8, 25 D. Boral Capital
    Buy
    Aug 1, 25 Wells Fargo
    Equal-Weight
    Jul 31, 25 Stifel
    Buy
    Jul 31, 25 Piper Sandler
    Neutral
    Jul 31, 25 Lake Street
    Buy
    Jul 31, 25 D. Boral Capital
    Buy
    May 22, 25 Citigroup
    Neutral
    May 1, 25 Piper Sandler
    Overweight
    May 1, 25 D. Boral Capital
    Buy
    May 1, 25 Canaccord Genuity
    Buy

    Institutional Ownership

    Screeners with LUNG included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Ex Dividend dates calendar
    • What is the ticker symbol for Pulmonx Corporation?
    • Does Pulmonx Corporation pay dividends?
    • What sector is Pulmonx Corporation in?
    • What industry is Pulmonx Corporation in?
    • What country is Pulmonx Corporation based in?
    • When did Pulmonx Corporation go public?
    • Is Pulmonx Corporation in the S&P 500?
    • Is Pulmonx Corporation in the NASDAQ 100?
    • Is Pulmonx Corporation in the Dow Jones?
    • When was Pulmonx Corporation's last earnings report?
    • When does Pulmonx Corporation report earnings?

    What is the ticker symbol for Pulmonx Corporation?

    The ticker symbol for Pulmonx Corporation is NASDAQ:LUNG

    Does Pulmonx Corporation pay dividends?

    No, Pulmonx Corporation does not pay dividends

    What sector is Pulmonx Corporation in?

    Pulmonx Corporation is in the Healthcare sector

    What industry is Pulmonx Corporation in?

    Pulmonx Corporation is in the Medical Devices industry

    What country is Pulmonx Corporation based in?

    Pulmonx Corporation is headquartered in United States

    When did Pulmonx Corporation go public?

    Pulmonx Corporation's initial public offering (IPO) was on October 1, 2020

    Is Pulmonx Corporation in the S&P 500?

    No, Pulmonx Corporation is not included in the S&P 500 index

    Is Pulmonx Corporation in the NASDAQ 100?

    No, Pulmonx Corporation is not included in the NASDAQ 100 index

    Is Pulmonx Corporation in the Dow Jones?

    No, Pulmonx Corporation is not included in the Dow Jones index

    When was Pulmonx Corporation's last earnings report?

    Pulmonx Corporation's most recent earnings report was on July 30, 2025

    When does Pulmonx Corporation report earnings?

    The next expected earnings date for Pulmonx Corporation is October 29, 2025
    On this page